Trade in substandard and falsified medicines
According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical capacity and poor governance contribute to th...
मुख्य लेखकों: | Hagen, N, Hauk, C, Heide, L |
---|---|
अन्य लेखक: | Brombacher, D |
स्वरूप: | Book section |
भाषा: | English |
प्रकाशित: |
Nomos
2022
|
समान संसाधन
-
Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
द्वारा: Hauk, C, और अन्य
प्रकाशित: (2021) -
Substandard and Falsified Medicines in Myanmar
द्वारा: Mirai Sakuda, और अन्य
प्रकाशित: (2020-03-01) -
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
द्वारा: Cavany, S, और अन्य
प्रकाशित: (2023) -
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
द्वारा: Sean Cavany, और अन्य
प्रकाशित: (2023-10-01) -
How to achieve international action on falsified and substandard medicines.
द्वारा: Attaran, A, और अन्य
प्रकाशित: (2012)